Evaluation and Management of Colorectal Cancer Hepatic Metastases
- PMID: 33872286
- DOI: 10.1097/DCR.0000000000002103
Evaluation and Management of Colorectal Cancer Hepatic Metastases
Abstract
A 65-year-old man presents with new liver lesions on surveillance imaging 2 years after a right hemicolectomy for cecal adenocarcinoma. The primary tumor was pT3N1, microsatellite stable, and KRAS wild type. He completed adjuvant FOLFOX. His CEA level is 22 ng/mL. There are two 1.5-cm lesions in the right lobe near the dome of the liver and a 4-cm lesion in segment II. No luminal recurrence is detected endoscopically, and there is no evidence of peritoneal or pulmonary disease.
Copyright © The ASCRS 2021.
Comment in
-
Expert Commentary on the Evaluation and Management of Colorectal Hepatic Metastases.Dis Colon Rectum. 2021 Jul 1;64(7):781-782. doi: 10.1097/DCR.0000000000002104. Dis Colon Rectum. 2021. PMID: 33902091 No abstract available.
References
-
- Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–259.
-
- Raoof M, Jutric Z, Haye S, et al. Systematic failure to operate on colorectal cancer liver metastases in California. Cancer Med. 2020;9:6256–6267.
-
- Renzulli M, Clemente A, Ierardi AM, et al. Imaging of colorectal liver metastases: new developments and pending issues. Cancers (Basel). 2020;12:E15110.3390/cancers12010151 - DOI
-
- Moulton CA, Gu CS, Law CH, et al. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA. 2014;311:1863–1869.
-
- Søreide JA, Deshpande R. Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management. Eur J Surg Oncol. 2021;47:216–224.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources